Lisinopril is an angiotensin converting enzyme inhibitor sold in the U.S. under 3 brand and generic names, for diabetic nephropathies, heart failure and hypertension. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
From the FDA label for Prinivil (application NDA019558). Other lisinopril products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
Hypertension: Initial adult dose is 10 mg once daily. Titrate up to 40 mg daily based on bloodpressure response. Initiate patients on diuretics at 5 mg once daily (2.1) • Pediatric patients with glomerular filtration rate > 30 mL/min/1.73m2 : Initial dose in patients 6years of age and older is 0.07 mg per kg (up to 5 mg total) once daily (2.1) • Heart Failure: Initiate with 5 mg once daily. Increase dose as tolerated to 40 mg daily (2.2) • Acute Myocardial Infarction (MI): Give 5 mg within 24 hours of MI. Followed by 5 mg after 24hours, then 10 mg once daily (2.3) • Renal Impairment: For patients with creatinine clearance ≥10 mL/min and ≤ 30 mL/min, halveusual initial dose. For patients with creatinine clearance < 10 mL/min or on hemodialysis, therecommended initial dose is 2.5 mg (2.4) 2.1 Hypertension Initial Therapy in adults: The recommended initial dose is 10 mg once a day. Dosage should be adjusted according to blood pressure response. The usual dosage range is 20 mg to 40 mg per day administered in a single daily dose. Doses up to 80 mg have been used but do not appear to give greater effect. Use with diuretics in adults If blood pressure is not controlled with lisinopril alone, a low dose of a diuretic may be added (e.g. hydrochlorothiazide, 12.5 mg). After the addition of a diuretic, it may be possible to reduce the dose of lisinopril.…
Common adverse reactions (events 2% greater than placebo) by use: Hypertension: headache, dizziness and cough ( 6.1) Heart Failure: hypotension and chest pain (6.1) Acute Myocardial Infarction: hypotension (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Exelan Pharmaceuticals, Inc. at 1-866-604-3268 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. Hypertension In clinical trials in patients with hypertension treated with lisinopril, 5.7% of patients on lisinopril discontinued with adverse reactions. The following adverse reactions (events 2% greater on lisinopril than on placebo) were observed with lisinopril alone: headache (by 3.8%), dizziness (by 3.5%), cough (by 2.5%). Heart Failure In patients with systolic heart failure treated with lisinopril for up to four years, 11% discontinued therapy with adverse reactions. In controlled studies in patients with heart failure, therapy was discontinued in 8.1% of patients treated with lisinopril for 12 weeks, compared to 7.7% of patients treated with placebo for 12 weeks. The following adverse reactions (events 2% greater on lisinopril…
Potassium-rich foods & salt substitutes
Don't use potassium-based salt substitutes unless your clinician approves, and ask before taking potassium supplements. Your clinician may check your potassium level with blood tests.
Lisinopril (an ACE inhibitor) — MedlinePlus (U.S. National Library of Medicine) ↗Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Typical price | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | Generic | $1 | View → | |
| 2 |
Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.
| Imprint | Strength | Colour | Shape | Maker |
|---|---|---|---|---|
| H150 | 10 mg / 12.5 mg | white | round | — |
| LL;B03 | 25 mg / 20 mg | orange | round | — |
| LL;B02 | 12.5 mg / 20 mg | yellow | round | — |
| LL;B01 | 12.5 mg / 10 mg | blue | hexagon (6 sided) | — |
| LL;B02 | 12.5 mg / 20 mg | yellow | round | — |
| LUPIN;10 |
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
Lupin Pharmaceuticals Inc. · Jun 20, 2025
Lisinopril Tablets
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Evaric Pharmaceuticals Inc. · Nov 15, 2024
The elimination half-life of lisinopril is about 12 hours (the effective half-life, in adults with normal kidney function). Lisinopril is not metabolized and is cleared unchanged by the kidneys, so its half-life is longer in people with reduced kidney function and in older adults; how much is absorbed also varies widely between individuals. The 12-hour figure is the label's "effective half-life of accumulation" (the clinically meaningful value), not a single-dose terminal half-life.
LISINOPRIL tablet — DailyMed (FDA label), Clinical Pharmacology / Pharmacokinetics ↗Half-life is how long the body takes to clear half a dose. It is not the same as how long a drug test can detect it, and it varies with age, kidney and liver function.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Lisinopril is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer lisinopril within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [seeWarnings and Precautions (5.2)].Lisinopril is contraindicated in patients with: • a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor • hereditary or idiopathic angioedemaDo not co-administer aliskiren with lisinopril in patients with diabetes [see Drug Interactions (7.4)] • Angioedema or a history of hereditary or idiopathic angioedema (4) • Hypersensitivity (4) • Co-administration of aliskiren with lisinopril in patients with diabetes (4, 7.4)
Diuretics: Excessive drop in blood pressure (7.1) • NSAIDS: Increased risk of renal impairment and loss of antihypertensive efficacy (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotensionand hyperkalemia (7.4) • Lithium: Symptoms of lithium toxicity (7.5) • Gold: Nitritoid reactions have been reported (7.6) • Concomitant mTOR inhibitor or neprilysin inhibitor use may increase angioedema risk (7.7, 7.8) 7.1 Diuretics Initiation of lisinopril in patients on diuretics may result in excessive reduction of blood pressure. The possibility of hypotensive effects with lisinopril can be minimized by either decreasing or discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with lisinopril. If this is not possible, reduce the starting dose of lisinopril [see Dosage and Administration (2.2) and Warnings and Precautions (5.4)]. Lisinopril attenuates potassium loss caused by thiazide-type diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, monitor the patient’s serum potassium frequently. 7.2 Antidiabetics Concomitant administration of lisinopril and antidiabetic medicines (insulins, oral hypoglycemic agents) may cause an increased…
| 72/100 |
| Prescription |
| Solution |
| Generic |
| $1 |
| View → |
| 3 | 70/100 | Prescription | Tablet | Generic | $1 | View → |
| 10 mg |
| pink |
| round |
| — |
| LUPIN;20 | 20 mg | pink | round | — |
|---|
| 5 | 5 mg | pink | round | — |
|---|